Showing results (101-110 of 903) with videos related to
Sort By:
Pageof 91
British Journal of Haematology|July 1, 1984
Leu-10 (HLA-DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA-DR expressionA Al-Katib, B KozinerBritish Journal of Urology|February 1, 1997
Unique synergism or antagonism of combinations of chemotherapeutic and hormonal agents in human prostate cancer cell linesW Kreis, D R Budman, A CalabroThe Mount Sinai Journal of Medicine, New York|August 22, 2001
Cutaneous granulomas masquerading as tuberculoid leprosy in a patient with congenital combined immunodeficiencyA I Krupnick, H Shim, R G Phelps, et al.Clinical and Experimental Immunology|July 27, 2001
Enhanced T cell apoptosis in common variable immunodeficiency: negative role of the fas/fasligand system and of the Bcl-2 family proteins and possible role of TNF-RSM Di Renzo, D Serrano, Z Zhou, et al.Chest|September 1, 1985
Pulmonary cell populations in the immunosuppressed patient. Bronchoalveolar lavage findings during episodes of pneumonitisD A White, R A Gellene, S Gupta, et al.Medicina|January 1, 1995
[Autologous transplantation of peripheral blood stem cells in malignant lymphomas]A Sánchez Luceros, B KozinerThe American Journal of Medicine|January 1, 1988
Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiencyJ Björkander, C Cunningham-Rundles, P Lundin, et al.Anti-Cancer Drugs|November 21, 1998
In vitro evaluation of synergism or antagonism with combinations of new cytotoxic agentsD R Budman, A Calabro, W KreisLeukemia|October 6, 2001
In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials?D R Budman, A Calabro, W KreisCancer Chemotherapy and Pharmacology|February 28, 2001
A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agentsW Kreis, D R Budman, A CalabroPageof 91